Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.0000 (-2.33%) ($20.6900 - $21.4500) on Thu. Mar. 23, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.13% (three month average) | RSI | 65 | Latest Price | $21.0000(-2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 8.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(56%) IBB(50%) ARKG(49%) IWO(48%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -2.565% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-10%) UNG(-3%) TIP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.565% (StdDev 5.13%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
5 Day Moving Average | $20.8(0.96%) | 10 Day Moving Average | $20.54(2.24%) | 20 Day Moving Average | $18.71(12.24%) | To recent high | -7.5% | To recent low | 66% | Market Cap | $1.56b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |